Nordea Investment Management Ab Crispr Therapeutics Ag Transaction History

Nordea Investment Management Ab

$92.5 Billion
Q1 2025

A detailed history of Nordea Investment Management Ab transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nordea Investment Management Ab holds 126,600 shares of CRSP stock, worth $4.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,600

Previous 125,400 0.96%

Holding current value

$4.59 Million

Previous $4.94 Million 12.71%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$34.03 - $53.02 $40,836 - $63,624	1,200 Added 0.96%	126,600 $4.31 Million
Q4 2024 Jan 06, 2025	BUY	$38.65 - $55.15 $204,845 - $292,295	5,300 Added 4.41%	125,400 $4.94 Million
Q3 2024 Nov 05, 2024	SELL	$44.62 - $62.75 $303,416 - $426,700	-6,800 Reduced 5.36%	120,100 $5.64 Million
Q2 2024 Aug 08, 2024	SELL	$51.17 - $68.18 $1.12 Million - $1.49 Million	-21,800 Reduced 14.66%	126,900 $6.85 Million
Q1 2024 May 02, 2024	BUY	$60.67 - $89.12 $2.61 Million - $3.84 Million	43,100 Added 40.81%	148,700 $10.1 Million
Q4 2023 Jan 10, 2024	SELL	$38.62 - $72.18 $96,550 - $180,450	-2,500 Reduced 2.31%	105,600 $6.61 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $580,992 - $755,200	12,800 Added 13.43%	108,100 $4.91 Million
Q2 2023 Jul 07, 2023	SELL	$43.47 - $67.77 $256,473 - $399,843	-5,900 Reduced 5.83%	95,300 $5.35 Million
Q1 2023 Apr 19, 2023	SELL	$41.0 - $56.12 $32,800 - $44,896	-800 Reduced 0.78%	101,200 $4.58 Million
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $552,579 - $925,947	14,100 Added 16.04%	102,000 $4.15 Million
Q3 2022 Oct 19, 2022	SELL	$61.1 - $83.78 $48,880 - $67,024	-800 Reduced 0.9%	87,900 $5.79 Million
Q2 2022 Aug 09, 2022	SELL	$43.23 - $73.83 $358,809 - $612,789	-8,300 Reduced 8.56%	88,700 $5.39 Million
Q1 2022 Apr 11, 2022	BUY	$53.19 - $79.24 $154,251 - $229,795	2,900 Added 3.08%	97,000 $6.27 Million
Q4 2021 Jan 20, 2022	BUY	$70.09 - $111.29 $1.3 Million - $2.06 Million	18,500 Added 24.47%	94,100 $7.55 Million
Q3 2021 Nov 01, 2021	SELL	$110.2 - $156.64 $8.33 Million - $11.8 Million	-75,600 Reduced 50.0%	75,600 $8.5 Million
Q3 2021 Nov 01, 2021	BUY	$110.2 - $156.64 $16.7 Million - $23.7 Million	151,200 New	151,200 $16.9 Million

Others Institutions Holding CRSP

# of Institutions

479

Shares Held

64.2M

Call Options Held

2.15M

Put Options Held

1.92M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $2.83B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Crispr Therapeutics Ag Transaction History